Macrophage polarization markers in subcutaneous, pericardial, and epicardial adipose tissue are altered in patients with coronary heart disease. 2023

Bianca Papotti, and Trine Baur Opstad, and Sissel Åkra, and Theis Tønnessen, and Bjørn Braathen, and Charlotte Holst Hansen, and Harald Arnesen, and Svein Solheim, and Ingebjørg Seljeflot, and Nicoletta Ronda
Department of Cardiology, Center for Clinical Heart Research, Oslo University Hospital Ullevål, Oslo, Norway.

Epicardial and pericardial adipose tissue (EAT and PAT) surround and protect the heart, with EAT directly sharing the microcirculation with the myocardium, possibly presenting a distinct macrophage phenotype that might affect the inflammatory environment in coronary heart disease (CHD). This study aims to investigate the expression of genes in different AT compartments driving the polarization of AT macrophages toward an anti-inflammatory (L-Galectin 9; CD206) or pro-inflammatory (NOS2) phenotype. EAT, PAT, and subcutaneous (SAT) biopsies were collected from 52 CHD patients undergoing coronary artery bypass grafting, and from 22 CTRLs undergoing aortic valve replacement. L-Galectin9 (L-Gal9), CD206, and NOS2 AT gene expression and circulating levels were analyzed through RT-PCR and ELISA, respectively. L-Gal9, CD206, and NOS2 gene expression was similar in all AT compartments in CHD and CTRLs, as were also L-Gal9 and CD206 circulating levels, while NOS2 serum levels were higher in CHD (p = 0.012 vs. CTRLs). In CTRLs, NOS2 expression was lower in EAT vs. SAT (p = 0.007), while in CHD patients CD206 expression was lower in both SAT and EAT as compared to PAT (p = 0.003, p = 0.006, respectively), suggestive of a possible macrophage reprogramming toward a pro-inflammatory phenotype in EAT. In CHD patients, NOS2 expression in SAT correlated to that in PAT and EAT (p = 0.007, both), CD206 expression correlated positively to L-Gal9 (p < 0.001) only in EAT, and CD206 expression associated with that of macrophage identifying markers in all AT compartments (p < 0.001, all). In CHD patients, subjects with LDL-C above 1.8 mmol/L showed significantly higher NOS2 expression in PAT and EAT as compared to subjects with LDL-C levels below (p < 0.05), possibly reflecting increased cardiac AT pro-inflammatory activation. In SAT and PAT, CD206 expression associated with BMI in both CHD and CTRLs (p < 0.05, all), and with L-Gal9 in EAT, however only in CTRLs (p = 0.002). CHD seems to be accompanied by an altered cardiac, and especially epicardial AT macrophage polarization. This may represent an important pathophysiological mechanism and a promising field of therapy targeting the excessive AT inflammation, in need of further investigation.

UI MeSH Term Description Entries

Related Publications

Bianca Papotti, and Trine Baur Opstad, and Sissel Åkra, and Theis Tønnessen, and Bjørn Braathen, and Charlotte Holst Hansen, and Harald Arnesen, and Svein Solheim, and Ingebjørg Seljeflot, and Nicoletta Ronda
April 2022, Atherosclerosis plus,
Bianca Papotti, and Trine Baur Opstad, and Sissel Åkra, and Theis Tønnessen, and Bjørn Braathen, and Charlotte Holst Hansen, and Harald Arnesen, and Svein Solheim, and Ingebjørg Seljeflot, and Nicoletta Ronda
July 2011, Journal of the American College of Cardiology,
Bianca Papotti, and Trine Baur Opstad, and Sissel Åkra, and Theis Tønnessen, and Bjørn Braathen, and Charlotte Holst Hansen, and Harald Arnesen, and Svein Solheim, and Ingebjørg Seljeflot, and Nicoletta Ronda
September 2017, Bulletin of experimental biology and medicine,
Bianca Papotti, and Trine Baur Opstad, and Sissel Åkra, and Theis Tønnessen, and Bjørn Braathen, and Charlotte Holst Hansen, and Harald Arnesen, and Svein Solheim, and Ingebjørg Seljeflot, and Nicoletta Ronda
October 2020, Journal of proteome research,
Bianca Papotti, and Trine Baur Opstad, and Sissel Åkra, and Theis Tønnessen, and Bjørn Braathen, and Charlotte Holst Hansen, and Harald Arnesen, and Svein Solheim, and Ingebjørg Seljeflot, and Nicoletta Ronda
June 2017, Journal of cardiology,
Bianca Papotti, and Trine Baur Opstad, and Sissel Åkra, and Theis Tønnessen, and Bjørn Braathen, and Charlotte Holst Hansen, and Harald Arnesen, and Svein Solheim, and Ingebjørg Seljeflot, and Nicoletta Ronda
December 2010, Academic radiology,
Bianca Papotti, and Trine Baur Opstad, and Sissel Åkra, and Theis Tønnessen, and Bjørn Braathen, and Charlotte Holst Hansen, and Harald Arnesen, and Svein Solheim, and Ingebjørg Seljeflot, and Nicoletta Ronda
November 2022, International heart journal,
Bianca Papotti, and Trine Baur Opstad, and Sissel Åkra, and Theis Tønnessen, and Bjørn Braathen, and Charlotte Holst Hansen, and Harald Arnesen, and Svein Solheim, and Ingebjørg Seljeflot, and Nicoletta Ronda
May 2019, Bioscience reports,
Bianca Papotti, and Trine Baur Opstad, and Sissel Åkra, and Theis Tønnessen, and Bjørn Braathen, and Charlotte Holst Hansen, and Harald Arnesen, and Svein Solheim, and Ingebjørg Seljeflot, and Nicoletta Ronda
January 2018, PloS one,
Bianca Papotti, and Trine Baur Opstad, and Sissel Åkra, and Theis Tønnessen, and Bjørn Braathen, and Charlotte Holst Hansen, and Harald Arnesen, and Svein Solheim, and Ingebjørg Seljeflot, and Nicoletta Ronda
February 2018, European journal of preventive cardiology,
Copied contents to your clipboard!